[go: up one dir, main page]

GB201706233D0 - Combination therapy - Google Patents

Combination therapy

Info

Publication number
GB201706233D0
GB201706233D0 GBGB1706233.2A GB201706233A GB201706233D0 GB 201706233 D0 GB201706233 D0 GB 201706233D0 GB 201706233 A GB201706233 A GB 201706233A GB 201706233 D0 GB201706233 D0 GB 201706233D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1706233.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADC Therapeutics SA
MedImmune Ltd
Original Assignee
ADC Therapeutics SA
MedImmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADC Therapeutics SA, MedImmune Ltd filed Critical ADC Therapeutics SA
Priority to GBGB1706233.2A priority Critical patent/GB201706233D0/en
Publication of GB201706233D0 publication Critical patent/GB201706233D0/en
Priority to PCT/EP2018/060210 priority patent/WO2018193103A1/en
Priority to EP18719163.0A priority patent/EP3612235A1/en
Priority to US16/605,710 priority patent/US20200129638A1/en
Ceased legal-status Critical Current

Links

GBGB1706233.2A 2017-04-20 2017-04-20 Combination therapy Ceased GB201706233D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB1706233.2A GB201706233D0 (en) 2017-04-20 2017-04-20 Combination therapy
PCT/EP2018/060210 WO2018193103A1 (en) 2017-04-20 2018-04-20 Combination therapy with an anti-psma antibody-drug conjugate
EP18719163.0A EP3612235A1 (en) 2017-04-20 2018-04-20 Combination therapy with an anti-psma antibody-drug conjugate
US16/605,710 US20200129638A1 (en) 2017-04-20 2018-04-20 Combination therapy with an anti-psma antibody-drug conjugate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1706233.2A GB201706233D0 (en) 2017-04-20 2017-04-20 Combination therapy

Publications (1)

Publication Number Publication Date
GB201706233D0 true GB201706233D0 (en) 2017-06-07

Family

ID=58795654

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1706233.2A Ceased GB201706233D0 (en) 2017-04-20 2017-04-20 Combination therapy

Country Status (1)

Country Link
GB (1) GB201706233D0 (en)

Similar Documents

Publication Publication Date Title
PT3618875T (en) Combination therapy
IL272560A (en) Combination therapy
GB201713914D0 (en) Combination therapy
GB201713113D0 (en) Combination therapy
GB201706243D0 (en) Combination therapy
GB201706239D0 (en) Combination therapy
GB201706225D0 (en) Combination therapy
GB201706226D0 (en) Combination therapy
GB201706227D0 (en) Combination therapy
GB201706228D0 (en) Combination therapy
GB201706229D0 (en) Combination therapy
GB201706230D0 (en) Combination therapy
GB201706231D0 (en) Combination therapy
GB201706232D0 (en) Combination therapy
GB201706234D0 (en) Combination therapy
GB201706235D0 (en) Combination therapy
GB201706236D0 (en) Combination therapy
GB201706248D0 (en) Combination therapy
GB201706238D0 (en) Combination therapy
GB201706247D0 (en) Combination therapy
GB201706240D0 (en) Combination therapy
GB201706241D0 (en) Combination therapy
GB201706242D0 (en) Combination therapy
GB201706223D0 (en) Combination therapy
GB201706244D0 (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)